Non-transplant cardiac surgery for end-stage dilated cardiomyopathy in small children

Area of Science:

• Cardiology
• Pediatric Surgery
• Transplantation Medicine

Background:

• End-stage dilated cardiomyopathy (DCM) presents significant challenges in pediatric patients requiring heart transplantation.
• Mechanical bridges have limitations in small children, necessitating alternative strategies.
• Non-transplant cardiac surgery has been explored as a potential biologic bridge to transplantation.

Purpose of the Study:

• To evaluate the efficacy of non-transplant cardiac surgery as a biologic bridge to heart transplantation in pediatric patients with end-stage DCM.
• To assess the clinical outcomes and surgical mortality associated with this approach.

Main Methods:

• A retrospective review of 7 pediatric patients with end-stage DCM referred for heart transplantation between October 1997 and December 2000.
• Patients received non-transplant cardiac surgery as a bridge to transplantation.
• Surgical mortality rates were analyzed based on urgency (emergency vs. urgent).

Main Results:

• Two patients died before surgery; the in-hospital surgical mortality rate was 50% overall.
• Emergency surgery in 4 patients had a 75% mortality rate.
• Urgent surgery in 2 patients had a 0% mortality rate.

Conclusions:

• Non-transplant cardiac surgery can serve as a viable biologic bridge to heart transplantation in pediatric patients with DCM and severe heart failure.
• The timing and urgency of surgery significantly impact outcomes.
• This strategy offers an alternative to mechanical support for small children awaiting cardiac transplantation.